SMSheryl S. Moy

Sheryl S. Moy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sheryl S. Moy has a total of 136 co-authors. Here are the top co-authors by number of shared publications:

  • Randal J. Nonneman

    Carolina Institute for Developmental Disabilities, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA; Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA

    6 shared publications
  • Lorinda K. Baker

    Carolina Institute for Developmental Disabilities, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA; Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA

    5 shared publications
  • Natallia V. Riddick

    Carolina Institute for Developmental Disabilities, University of North Carolina School of Medicine, Chapel Hill, NC, 27599, USA; Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC, 27599, USA

    5 shared publications
  • Viktoriya D. Nikolova

    Carolina Institute for Developmental Disabilities, University of North Carolina School of Medicine, Chapel Hill, NC, 27599, USA; Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC, 27599, USA

    5 shared publications
  • Beverly H. Koller

    Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA

    4 shared publications
  • Jessica J. Nadler

    Carolina Institute for Developmental Disabilities, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA; Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA

    4 shared publications

Latest Publications

  • Open Access

    Content and performance of the MiniMUGA genotyping array, a new tool to improve rigor and reproducibility in mouse research

    by John Sebastian Sigmon, Matthew W Blanchard, Ralph S Baric, Timothy A Bell, Jennifer Brennan, Gudrun A Brockmann, A Wesley Burks, J Mauro Calabrese, Kathleen M Caron, Richard E Cheney, et al.

    The laboratory mouse is the most widely used animal model for biomedical research, due in part to its well annotated genome, wealth of genetic resources and the ability to precisely manipulate its genome. Despite the importance of genetics for mouse research, genetic quality control (QC) is not standardized, in part due to the lack of cost effective, informative and robust platforms. Genotyping arrays are standard tools for mouse research and remain an attractive alternative even in the era of high-throughput whole genome sequencing. Here we describe the content and performance of a new Mouse Universal Genotyping Array (MUGA). MiniMUGA, an array-based genetic QC platform with over 11,000 probes. In addition to robust discrimination between most classical and wild-derived laboratory strains, MiniMUGA was designed to contain features not available in other platforms: 1) chromosomal sex determination, 2) discrimination between substrains from multiple commercial vendors, 3) diagnostic SNPs for popular laboratory strains, 4) detection of constructs used in genetically engineered mice, and 5) an easy to interpret report summarizing these results. In-depth annotation of all probes should facilitate custom analyses by individual researchers. To determine the performance of MiniMUGA we genotyped 6,899 samples from a wide variety of genetic backgrounds. The performance of MiniMUGA compares favorably with three previous iterations of the MUGA family of arrays both in discrimination capabilities and robustness. We have generated publicly available consensus genotypes for 241 inbred strains including classical, wild-derived and recombinant inbred lines. Here we also report the detection of a substantial number of XO and XXY individuals across a variety of sample types, the extension of the utility of reduced complexity crosses to genetic backgrounds other than C57BL/6, and the robust detection of 17 genetic constructs. There is preliminary but striking evidence that the array can be used to identify both partial sex chromosome duplication and mosaicism, and that diagnostic SNPs can be used to determine how long inbred mice have been bred independently from the main stock for a significant action of the genotyped inbred samples. We conclude that MiniMUGA is a valuable platform for genetic QC and important new tool to the increase rigor and reproducibility of mouse research.


  • Prosocial effects of an oxytocin metabolite, but not synthetic oxytocin receptor agonists, in a mouse model of autism

    by Sheryl S. Moy, Brian L. Teng, Viktoriya D. Nikolova, Natallia V. Riddick, Catherine D. Simpson, Amy Van Deusen, William P. Janzen, Maria F. Sassano, Cort A. Pedersen, Michael B. Jarstfer


  • Open Access

    Reversal of social deficits by subchronic oxytocin in two autism mouse models

    by Brian L. Teng, Viktoriya D. Nikolova, Natallia V. Riddick, Kara L. Agster, James J. Crowley, Lorinda K. Baker, Beverly H. Koller, Cort A. Pedersen, Michael B. Jarstfer, Sheryl S. Moy


  • Repetitive behavior profile and supersensitivity to amphetamine in the C58/J mouse model of autism

    by Sheryl S. Moy, Natallia V. Riddick, Viktoriya D. Nikolova, Brian L. Teng, Kara L. Agster, Randal J. Nonneman, Nancy B. Young, Lorinda K. Baker, Jessica J. Nadler, James W. Bodfish


  • Behavioral deficits in an Angelman syndrome model: Effects of genetic background and age

    by Hsien-Sung Huang, Andrew J. Burns, Randal J. Nonneman, Lorinda K. Baker, Natallia V. Riddick, Viktoriya D. Nikolova, Thorfinn T. Riday, Koji Yashiro, Benjamin D. Philpot, Sheryl S. Moy


  • Disruption of social approach by MK-801, amphetamine, and fluoxetine in adolescent C57BL/6J mice

    by Sheryl S. Moy, Randal J. Nonneman, Geoffrey O. Shafer, Viktoriya D. Nikolova, Natallia V. Riddick, Kara L. Agster, Lorinda K. Baker, Darin J. Knapp


  • Preweaning Sensorimotor Deficits and Adolescent Hypersociability in Grin1 Knockdown Mice

    by Sheryl S. Moy, Viktoriya D. Nikolova, Natallia V. Riddick, Lorinda K. Baker, Beverly H. Koller

    Mice with knockdown of the N-methyl-d-aspartate (NMDA) receptor NR1 subunit, encoded by the gene Grin1, have been investigated as a model for the intrinsic NMDA hypofunction hypothesized for schizophrenia. Previous work has shown that adult Grin1 mutant mice have overt deficits in habituation and sensorimotor gating, exaggerated reactivity to environmental stimuli, reduced social approach, and other alterations that reflect behavioral manifestations of schizophrenia. In humans, the emergence of overt symptoms of the disorder typically occurs in adolescence or early adulthood, suggesting a role for aberrant maturation of NMDA receptor signaling in symptom onset. The following study evaluated Grin1 mutant mice for abnormal behavioral phenotypes during the preweaning, adolescent, and adult periods. Measures included open field activity, prepulse inhibition of acoustic startle responses, and social preference in a three-chamber choice task. Mice from the C57BL/6J inbred strain, one of the parental strains for the Grin1 line, were also tested. The results showed that developmental reduction of NMDA receptor function led to significant alterations in behavior during the second and third weeks of life, including exaggerated startle responses and sensorimotor gating deficits on postnatal day 13, and pronounced hypersociability in adolescence. Male Grin1 mutant mice were more susceptible than female mice to the detrimental effects of decreased NMDA signaling. Overall, these findings provide evidence that reduced Grin1 function leads to abnormal phenotypes in the preweaning period, and that deficient NMDA signaling can lead to both overt hypersociability or marked asociality, dependent upon sex and age.


  • Impaired sociability and cognitive function in Nrcam-null mice

    by Sheryl S. Moy, Randal J. Nonneman, Nancy B. Young, Galina P. Demyanenko, Patricia F. Maness


  • Open Access

    Deficient NRG1-ERBB signaling alters social approach: relevance to genetic mouse models of schizophrenia

    by Sheryl S. Moy, H. Troy Ghashghaei, Randal J. Nonneman, Jill M. Weimer, Yukako Yokota, Daekee Lee, Cary Lai, David W. Threadgill, E. S. Anton

    Growth factor Neuregulin 1 (NRG1) plays an essential role in development and organization of the cerebral cortex. NRG1 and its receptors, ERBB3 and ERBB4, have been implicated in genetic susceptibility for schizophrenia. Disease symptoms include asociality and altered social interaction. To investigate the role of NRG1-ERBB signaling in social behavior, mice heterozygous for an Nrg1 null allele (Nrg1+/−), and mice with conditional ablation of Erbb3 or Erbb4 in the central nervous system, were evaluated for sociability and social novelty preference in a three-chambered choice task. Results showed that deficiencies in NRG1 or ERBB3 significantly enhanced sociability. All of the mutant groups demonstrated a lack of social novelty preference, in contrast to their respective wild-type controls. Effects of NRG1, ERBB3, or ERBB4 deficiency on social behavior could not be attributed to general changes in anxiety-like behavior, activity, or loss of olfactory ability. Nrg1+/− pups did not exhibit changes in isolation-induced ultrasonic vocalizations, a measure of emotional reactivity. Overall, these findings provide evidence that social behavior is mediated by NRG1-ERBB signaling.


  • Open Access

    Social approach in genetically engineered mouse lines relevant to autism

    by S. S. Moy, J. J. Nadler, N. B. Young, R. J. Nonneman, A. W. Grossman, D. L. Murphy, A. J. D’ercole, J. N. Crawley, T. R. Magnuson, J. M. Lauder

    Profound impairment in social interaction is a core symptom of autism, a severe neurodevelopmental disorder. Deficits can include a lack of interest in social contact and low levels of approach and proximity to other children. In this study, a three‐chambered choice task was used to evaluate sociability and social novelty preference in five lines of mice with mutations in genes implicated in autism spectrum disorders. Fmr1tm1Cgr/Y(Fmr1−/y) mice represent a model for fragile X, a mental retardation syndrome that is partially comorbid with autism. We tested Fmr1−/ymice on two genetic backgrounds, C57BL/6J and FVB/N‐129/OlaHsd (FVB/129). Targeted disruption of Fmr1 resulted in low sociability on one measure, but only when the mutation was expressed on FVB/129. Autism has been associated with altered serotonin levels and polymorphisms in SLC6A4 (SERT), the serotonin transporter gene. Male mice with targeted disruption of Slc6a4 displayed significantly less sociability than wild‐type controls. Mice with conditional overexpression of Igf‐1 (insulin‐like growth factor‐1) offered a model for brain overgrowth associated with autism. Igf‐1 transgenic mice engaged in levels of social approach similar to wild‐type controls. Targeted disruption in other genes of interest, En2 (engrailed‐2) and Dhcr7, was carried on genetic backgrounds that showed low levels of exploration in the choice task, precluding meaningful interpretations of social behavior scores. Overall, results show that loss of Fmr1 or Slc6a4 gene function can lead to deficits in sociability. Findings from the fragile X model suggest that the FVB/129 background confers enhanced susceptibility to consequences of Fmr1 mutation on social approach.